Mitek to Report Second Quarter Fiscal 2017 Financial Results on April 27, 2017
Apr 20, 2017 11:01 am UTC| Business
SAN DIEGO, April 20, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that it will release its financial results for the...
Mitek to Report Second Quarter Fiscal 2017 Financial Results on April 27, 2017
Apr 20, 2017 11:01 am UTC| Business
SAN DIEGO, April 20, 2017 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that it will release its financial results for the...
David Steenblock, D.O., Uses Stem Cells and Other Therapies for Stroke Patients
Apr 20, 2017 11:01 am UTC| Business
SAN CLEMENTE, Calif., April 20, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, uses stem cells and other therapies to achieve significant and improved lifestyle outcomes for many stroke...
David Steenblock, D.O., Uses Stem Cells and Other Therapies for Stroke Patients
Apr 20, 2017 11:01 am UTC| Business
SAN CLEMENTE, Calif., April 20, 2017 -- David Steenblock, an osteopathic physician based in San Clemente, CA, uses stem cells and other therapies to achieve significant and improved lifestyle outcomes for many stroke...
Key Appointment to Board of Directors at Cianna Medical, Inc.
Apr 20, 2017 11:01 am UTC| Business
ALISO VIEJO, Calif., April 20, 2017 -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that David M. Renzi has been elected to the Board of Directors. Cianna Medical manufactures and...
Key Appointment to Board of Directors at Cianna Medical, Inc.
Apr 20, 2017 11:01 am UTC| Business
ALISO VIEJO, Calif., April 20, 2017 -- Cianna Medical, Inc., the world leader in wire-free breast localization, announced that David M. Renzi has been elected to the Board of Directors. Cianna Medical manufactures and...
Apr 20, 2017 11:01 am UTC| Business
EDISON, NJ, April 20, 2017 -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced new data...